Sinocelltech Group Ltd
SSE:688520

Watchlist Manager
Sinocelltech Group Ltd Logo
Sinocelltech Group Ltd
SSE:688520
Watchlist
Price: 37.71 CNY -6.61% Market Closed
Market Cap: 16.8B CNY
Have any thoughts about
Sinocelltech Group Ltd?
Write Note

Relative Value

The Relative Value of one Sinocelltech Group Ltd stock under the Base Case scenario is 83.97 CNY. Compared to the current market price of 37.71 CNY, Sinocelltech Group Ltd is Undervalued by 55%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
83.97 CNY
Undervaluation 55%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
85
vs Industry
50
Median 3Y
23.9
Median 5Y
29.3
Industry
7.7
Forward
5.9
vs History
vs Industry
Median 3Y
-54
Median 5Y
-51
Industry
22.7
Forward
51.1
vs History
vs Industry
Median 3Y
-55
Median 5Y
-45.2
Industry
21.6
vs History
9
vs Industry
3
Median 3Y
-47
Median 5Y
-47
Industry
25.2
vs History
vs Industry
Median 3Y
-53.7
Median 5Y
-37
Industry
2.5
vs History
85
vs Industry
40
Median 3Y
24.1
Median 5Y
29.6
Industry
7.7
Forward
6.5
vs History
69
vs Industry
40
Median 3Y
25.1
Median 5Y
15
Industry
9
vs History
19
vs Industry
2
Median 3Y
-28.3
Median 5Y
-30.1
Industry
4.2
Forward
32.1
vs History
19
vs Industry
2
Median 3Y
-28.3
Median 5Y
-30.1
Industry
4.1
Forward
19.2
vs History
vs Industry
Median 3Y
-58.2
Median 5Y
-49.9
Industry
5.7
vs History
vs Industry
Median 3Y
-25.2
Median 5Y
-27.1
Industry
3.6
vs History
90
vs Industry
24
Median 3Y
17.3
Median 5Y
19.8
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Sinocelltech Group Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Sinocelltech Group Ltd
SSE:688520
16.8B CNY 7.7 -99.5 50.2 50.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.2B USD 10.9 -242.3 24.1 25.3
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.3B USD 5.9 17.5 15.9 17.7
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.8B EUR 18.7 -131 -105.5 -76.9
P/E Multiple
Earnings Growth
CN
Sinocelltech Group Ltd
SSE:688520
Average P/E: 208.2
Negative Multiple: -99.5
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -242.3
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.5
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -131 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Sinocelltech Group Ltd
SSE:688520
Average EV/EBITDA: 21.9
50.2
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.1
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.9
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.5 N/A
EV/EBIT Multiple
EBIT Growth
CN
Sinocelltech Group Ltd
SSE:688520
Average EV/EBIT: 26.4
50.2
1 641%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.3
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.7
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.9 N/A

See Also

Discover More
Back to Top